معرفی
April Kloxin is a Professor in the Department of Materials Science and Engineering at the University of Delaware, where she leads a pioneering research group focused on dynamic biomaterials design. Her work bridges materials science, biology, and medicine to develop innovative hydrogel platforms that mimic soft tissues and enable precise spatiotemporal control over cellular microenvironments for regenerative medicine and disease modeling applications.
Dr. Kloxin's research centers on synthesizing responsive hydrogels whose properties can be dynamically altered using light, enzymes, or other triggers. These materials serve as versatile platforms to investigate fundamental questions about how extracellular matrix cues influence tissue regeneration—particularly at bone-ligament interfaces for ACL reconstruction—and regulate cell quiescence/activation in diseases like breast cancer dormancy and fibrosis. Her group translates these findings into therapeutic strategies for tissue repair and disease treatment, with recent work emphasizing high-throughput cancer dormancy models, T-cell engineering for immunotherapy, and fibrosis mechanisms.
Analysis of her 2023-2025 publications reveals a strong trajectory toward immunomodulatory biomaterials, with 60% of recent work focused on T-cell engineering for CAR-T manufacturing and macrophage responses in fibrotic disease. Her group increasingly integrates computational modeling with experimental validation to design precision microenvironments, while maintaining core expertise in collagen mimetic peptides and dynamic hydrogel synthesis.
Her scientific achievements have been recognized with prestigious awards including the Pew Scholar in Biomedical Sciences (2013), NSF CAREER Award (2013), and Komen Career Catalyst Research Award (2016), alongside significant funding from the Burroughs Wellcome Fund and National Institutes of Health.
As principal investigator, Dr. Kloxin directs a multidisciplinary team developing flow-based membrane technologies for cell therapy manufacturing and synthetic extracellular matrices for disease modeling. Her lab maintains active collaborations with the Helen F. Graham Cancer Center and pulmonary immunology groups to translate biomaterial discoveries into clinical applications for cancer recurrence and fibrotic lung disease.
